Dr Reddys Laboratories has launched Amlodipine Besylate and Atorvastatin calcium tablets in the US market following the approval by the United States Food & Drug Administration (USFDA).

The tablets will be available in 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg and 10/80mg a therapeutic equivalent generic version of Caduet tablets.

The Caduet tablets brand and generic had US sales approximately USD 163 million MAT for the most recent twelve months ending in January 2014 according to IMS health.

Shares of the company declined Rs 10.05, or 0.38%, to trade at Rs 2,626. The total volume of shares traded was 11,253 at the BSE (10.23 a.m., Thursday).